Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
AP

NASDAQ · APYX

Apyx Medical Corporation

Healthcare · Medical - Devices

$2.60

Down-$0.09 (-3.35%)

Updated Nov 1, 2026, 7:13 PM

SID Score

3.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
134.17M
P/E ratio
-9.16
Dividend yield
0.00%
52-week range
$2.25 – $5.08
Volume
38.09K
Avg. volume
107.62K

Price performance · APYX

APYX price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

APYX closed at $2.60 after 20 trading sessions, up 0.00% for the selected period.

Last close
$2.60
Period change
+0.00%
Period low
$2.36
Period high
$2.69
Daily close
View OHLC price history
APYX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$2.61$2.65$2.53$2.6038.09K
Oct 29, 2026$2.60$2.69$2.48$2.6967.4K
Oct 28, 2026$2.53$2.61$2.515$2.6134.81K
Oct 27, 2026$2.45$2.527$2.41$2.5046.24K
Oct 26, 2026$2.37$2.47$2.35$2.46128.81K
Oct 23, 2026$2.39$2.40$2.25$2.37146.27K
Oct 22, 2026$2.46$2.53$2.34$2.41187.33K
Oct 21, 2026$2.47$2.513$2.42$2.5170.32K
Oct 20, 2026$2.45$2.56$2.42$2.44366.57K
Oct 19, 2026$2.55$2.56$2.35$2.42223.59K
Oct 16, 2026$2.60$2.65$2.54$2.5553.99K
Oct 15, 2026$2.4503$2.58$2.4503$2.56151.91K
Oct 14, 2026$2.59$2.59$2.49$2.5738.75K
Oct 13, 2026$2.68$2.68$2.48$2.60148.85K
Oct 12, 2026$2.62$2.73$2.53$2.6579.99K
Oct 9, 2026$2.38$2.62$2.38$2.59107.41K
Oct 8, 2026$2.54$2.54$2.34$2.36231.4K
Oct 7, 2026$2.52$2.60$2.4901$2.5534.8K
Oct 6, 2026$2.63$2.63$2.53$2.545129.27K
Oct 5, 2026$2.53$2.63$2.50$2.6068.39K

Latest APYX news

The latest Smart Investors Daily articles mentioning APYX.

Stock researchCompany · Overview

APYX research

Overview

Company profile and research snapshot.

Company profile

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$8.50
Implied upside
—
Analysts
—
APYX recent ratings
DateFirmRatingTarget
Sep 29, 2026Maxim GroupBuy—
Jul 13, 2026HC Wainwright & Co.Buy—
Mar 11, 2026Craig-HallumBuy—
Mar 11, 2026BTIGBuy—
Dec 16, 2025Roth CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 22, 2026

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026

CLEARWATER, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that its financial results for the third quarter of fiscal year 2026 will be released before markets open on Thursday, November 5th. Management will host a conference call at 8:00 a.m. Eastern Time on Thursday, November 5th, to discuss the results

Yahoo · Oct 21, 2026

Apyx Medical Corporation to Participate in Upcoming Investor Conferences

CLEARWATER, Fla., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that management will present at the following investor conferences: UBS Global Healthcare Conference – November 9-11, 2026 (Miami, FL)Management will participate in a fireside chat at 10:15am ET and will host one-on-one meetings with investors on Mon

Yahoo · Sep 29, 2026

Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

Patients reported high satisfaction and visible improvements in skin elasticity, youthfulness, and radianceCLEARWATER, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced results from a prospective clinical study evaluating the effects of Renuvion helium plasma radiofrequency technology on biological markers o

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By